Targeting tumor endothelial hyperglycolysis enhances immunotherapy through remodeling tumor microenvironment
Authors:
Open Access
- 22 February 2022
- journal article
- research article
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 12 (4) , 1825-1839
Abstract
No abstract availableKeywords
Funding Information
- Double First Class University Plan (CPU2018GF01)
- Project 333 of Jiangsu Province
- National Natural Science Foundation of China (82073929, 82103318, 82104184, 82173887)
- China Postdoctoral Science Foundation (2020M671662, 2020Z152, 2020Z354)
- National Key Research and Development Program of China (2017YFA0205400)
This publication has 57 references indexed in Scilit:
- Quantitative determinants of aerobic glycolysis identify flux through the enzyme GAPDH as a limiting stepeLife, 2014
- Role of PFKFB3-Driven Glycolysis in Vessel SproutingCell, 2013
- Posttranscriptional Control of T Cell Effector Function by Aerobic GlycolysisCell, 2013
- PD-1 Blockade Enhances T-cell Migration to Tumors by Elevating IFN-γ Inducible ChemokinesCancer Research, 2012
- TEM8/ANTXR1 Blockade Inhibits Pathological Angiogenesis and Potentiates Tumoricidal Responses against Multiple Cancer TypesCancer Cell, 2012
- Molecular mechanisms and clinical applications of angiogenesisNature, 2011
- Endothelial cells dynamically compete for the tip cell position during angiogenic sproutingNature Cell Biology, 2010
- Target identification using drug affinity responsive target stability (DARTS)Proceedings of the National Academy of Sciences, 2009
- Tumor AngiogenesisNew England Journal of Medicine, 2008
- In-gel digestion for mass spectrometric characterization of proteins and proteomesNature Protocols, 2006